- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beijing Tiantan Biological Products Corp Ltd (600161)
Beijing Tiantan Biological Products Corp Ltd stock price live, this page displays SS 600161 stock exchange data. View the 600161 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beijing Tiantan Biological Products Corp Ltd real time stock price chart below.
What Is the Beijing Tiantan Biological Products Corp Ltd Stock Price Today?
The Beijing Tiantan Biological Products Corp Ltd stock price today is 12.05.
What Is the Stock Symbol for Beijing Tiantan Biological Products Corp Ltd?
The stock symbol for Beijing Tiantan Biological Products Corp Ltd is "600161."
What Stock Exchange Does Beijing Tiantan Biological Products Corp Ltd Trade On?
Beijing Tiantan Biological Products Corp Ltd is listed and trades on the Shanghai stock exchange.
Is Beijing Tiantan Biological Products Corp Ltd a Good Stock to Buy?
Determining whether Beijing Tiantan Biological Products Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600161 quote. (ISIN: CNE000000WF9)
What Is the Beijing Tiantan Biological Products Corp Ltd Stock Price Today?
The Beijing Tiantan Biological Products Corp Ltd stock price today is 12.05.
What Is the Stock Symbol for Beijing Tiantan Biological Products Corp Ltd?
The stock symbol for Beijing Tiantan Biological Products Corp Ltd is "600161."
What Stock Exchange Does Beijing Tiantan Biological Products Corp Ltd Trade On?
Beijing Tiantan Biological Products Corp Ltd is listed and trades on the Shanghai stock exchange.
Is Beijing Tiantan Biological Products Corp Ltd a Good Stock to Buy?
Determining whether Beijing Tiantan Biological Products Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600161 quote. (ISIN: CNE000000WF9)
Shanghai
Currency in CNY
12.05
-0.37(-2.98%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.03
12.52
52 wk Range
11.12
22.08
600161 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.0312.52
52 wk Range
11.1222.08
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600161 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
18.70
Upside
+55.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Tiantan Bio receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Tiantan Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 18.70
(+55.19% Upside)
Earnings
Latest Release
Apr 30, 2026
EPS / Forecast
0.06 / 0.15
Revenue / Forecast
1.14B / 1.44B
Compare 600161 to Peers and Sector
Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.3x | 33.0x | −0.3x | |
PEG Ratio | −0.73 | 0.01 | 0.00 | |
Price/Book | 2.1x | 1.9x | 2.6x | |
Price / LTM Sales | 4.1x | 5.2x | 3.0x | |
Upside (Analyst Target) | 53.0% | 42.8% | 55.4% | |
Fair Value Upside | Unlock | 22.9% | 8.8% | Unlock |
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Beijing Tiantan Bio (600161) Stock Price Today?
The Beijing Tiantan Bio stock price today is 12.05 CNY.
What Stock Exchange Does Beijing Tiantan Bio Trade On?
Beijing Tiantan Bio is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Beijing Tiantan Bio?
The stock symbol for Beijing Tiantan Bio is "600161."
Does Beijing Tiantan Bio Pay Dividends? What’s The Current Dividend Yield?
The Beijing Tiantan Bio dividend yield is 1.99%.
What Is the Beijing Tiantan Bio Market Cap?
As of today, Beijing Tiantan Bio market cap is 24.56B CNY.
What Is Beijing Tiantan Bio's Earnings Per Share (TTM)?
The Beijing Tiantan Bio EPS (TTM) is 0.49.
When Is the Next Beijing Tiantan Bio Earnings Date?
Beijing Tiantan Bio will release its next earnings report on Aug 29, 2026.
From a Technical Analysis Perspective, Is 600161 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beijing Tiantan Bio Stock Split?
Beijing Tiantan Bio has split 9 times.
How Many Employees Does Beijing Tiantan Bio Have?
Beijing Tiantan Bio has 5205 employees.
What is the current trading status of Beijing Tiantan Bio (600161)?
As of Jul 24, 2026, Beijing Tiantan Bio (600161) is trading at a price of 12.05 CNY, with a previous close of 12.42 CNY. The stock has fluctuated within a day range of 12.03 CNY to 12.52 CNY, while its 52-week range spans from 11.12 CNY to 22.08 CNY.
What Is Beijing Tiantan Bio (600161) Price Target According to Analysts?
The average 12-month price target for Beijing Tiantan Bio is 18.70 CNY, with a high estimate of 24 CNY and a low estimate of 13.4 CNY. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +55.19% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.